Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation

Severe cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) strongly hampered the broad clinical applicability of chimeric antigen receptor T cell (CAR-T) therapy. Vascular endothelial activation has been suggested to contribute to the development of CRS...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yunshuo, Li, Ranran, Shang, Siqi, Yang, Xuejiao, Li, Lei, Wang, Wenbo, Wang, Yueying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170323/
https://www.ncbi.nlm.nih.gov/pubmed/34093519
http://dx.doi.org/10.3389/fimmu.2021.623610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170323/
https://www.ncbi.nlm.nih.gov/pubmed/34093519
http://dx.doi.org/10.3389/fimmu.2021.623610

Ejemplares similares